The autophagy protein RUBCNL/PACER represses RIPK1 kinase-dependent apoptosis and necroptosis
Diego Rojas-Rivera1,2, Sebastián Beltrán3,4,5, Francisco Muñoz-Carvajal1
1Cell Death & Biomedicine Laboratory, Centro de Biomedicina, Universidad Mayor, Santiago, Chile.
Abstract:
Mesenchymal stem cells (MSCs) are used in cell therapy; nonetheless, their application is limited by their poor survival after transplantation in a proinflammatory microenvironment. Macroautophagy/autophagy activation in MSCs constitutes a stress adaptation pathway, promoting cellular homeostasis. Our proteomics data indicate that RUBCNL/PACER (RUN and cysteine rich domain containing beclin 1 interacting protein like), a positive regulator of autophagy, is also involved in cell death. Hence, we screened MSC survival upon various cell death stimuli under loss or gain of function of RUBCNL. MSCs were protected from TNF (tumor necrosis factor)-induced regulated cell death when RUBCNL was expressed. TNF promotes inflammation by inducing RIPK1 kinase-dependent apoptosis or necroptosis. We determine that MSCs succumb to RIPK1 kinase-dependent apoptosis upon TNF sensing and necroptosis when caspases are inactivated. We show that RUBCNL is a negative regulator of both RIPK1-dependent apoptosis and necroptosis. Furthermore, RUBCNL mutants that lose the ability to regulate autophagy, retain their function in negatively regulating cell death. We also found that RUBCNL forms a complex with RIPK1, which disassembles in response to TNF. In line with this finding, RUBCNL expression limits assembly of RIPK1-TNFRSF1A/TNFR1 complex I, suggesting that complex formation between RUBCNL and RIPK1 represses TNF signaling. These results provide new insights into the crosstalk between the RIPK1-mediated cell death and autophagy machineries and suggest that RUBCNL, due to its functional duality in autophagy and apoptosis/necroptosis, could be targeted to improve the therapeutic efficacy of MSCs. Abbreviations: BAF: bafilomycin A1; CASP3: caspase 3; Caspases: cysteine-aspartic proteases; cCASP3: cleaved CASP3; CQ: chloroquine; CHX: cycloheximide; cPARP: cleaved poly (ADP-ribose) polymerase; DEPs: differential expressed proteins; ETO: etoposide; MEF: mouse embryonic fibroblast; MLKL: mixed lineage kinase domain-like; MSC: mesenchymal stem cell; MTORC1: mechanistic target of rapamycin kinase complex 1; Nec1s: necrostatin 1s; NFKB/NF-kB: nuclear factor of kappa light polypeptide gene enhancer in B cells; PLA: proximity ligation assay; RCD: regulated cell death; RIPK1: receptor (TNFRSF)-interacting serine-threonine kinase 1; RIPK3: receptor-interacting serine-threonine kinase 3; RUBCNL/PACER: RUN and cysteine rich domain containing beclin 1 interacting protein like; siCtrl: small interfering RNA nonsense; siRNA: small interfering RNA; TdT: terminal deoxynucleotidyl transferase; Tm: tunicamycin; TNF: tumor necrosis factor; TNFRSF1A/TNFR1: tumor necrosis factor receptor superfamily, member 1a.
Insights
RUBCNL protects mesenchymal stem cells (MSCs) from TNF-induced cell death by inhibiting RIPK1 signaling. This protein
Area of Science:
- Cell Biology
- Immunology
- Biochemistry
Background:
- Mesenchymal stem cells (MSCs) are crucial for cell therapy but exhibit poor survival in inflammatory environments.
- Autophagy activation is a stress response in MSCs, maintaining cellular homeostasis.
- RUBCNL/PACER, a known autophagy regulator, also influences cell death pathways.
Purpose of the Study:
- To investigate the role of RUBCNL in MSC survival under stress conditions.
- To elucidate the mechanism by which RUBCNL affects tumor necrosis factor (TNF)-induced cell death.
- To explore RUBCNL's potential as a therapeutic target for enhancing MSC efficacy.
Main Methods:
- Proteomics analysis to identify RUBCNL's involvement in cell death.
- Functional screening of MSCs with altered RUBCNL expression under various cell death stimuli.
- Analysis of RIPK1-dependent apoptosis and necroptosis pathways.
- Co-immunoprecipitation and complex formation assays to study RUBCNL-RIPK1 interactions.
- Assessment of RUBCNL's impact on TNF signaling complex assembly.
Main Results:
- RUBCNL expression protected MSCs from TNF-induced regulated cell death (RCD).
- RUBCNL negatively regulated both RIPK1-dependent apoptosis and necroptosis.
- RUBCNL's cell death regulatory function was independent of its autophagy regulatory role.
- RUBCNL formed a complex with RIPK1, which disassembled upon TNF stimulation.
- RUBCNL limited the assembly of the RIPK1-TNFRSF1A/TNFR1 complex, repressing TNF signaling.
Conclusions:
- RUBCNL acts as a negative regulator of TNF-induced apoptosis and necroptosis in MSCs.
- RUBCNL's dual role in autophagy and cell death pathways offers a novel therapeutic target.
- Targeting RUBCNL could improve MSC survival and therapeutic efficacy in inflammatory conditions.
Related Concept Videos
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
PI3K/mTOR/AKT Signaling Pathway
Regulation of the Unfolded Protein Response
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway


